clinical trial · NCT06895356
A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants
AbbVie·phase1·completed·n = 83
Healthy VolunteerTavapadon
brief summary
This study will assess the relative bioavailability of two different Oral formulations of tavapadon in healthy adult participants.
started
Mar 26, 2025
primary completion
Jun 16, 2025
completion
Jun 16, 2025
last updated
Jun 26, 2025
official title
A Phase 1, Two Part, Randomized, Single and Multiple Dose Crossover Study to Assess the Relative Bioavailability Between Tavapadon Clinical and Commercial Tablets
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol